Tyler F. Hayes

Tyler F. Hayes is a Principal at Thuja Capital, a position he has held since February 2023. His educational background is impressive, featuring an MD from Harvard Medical School, an MRes in Translational Cancer Medicine from King's College London, an MBA from London Business School, and a BSc in Cell & Molecular Biology from Duke University. Prior to joining Thuja Capital, he worked as a consultant at the Boston Consulting Group and interned at Novartis Venture.123

Hayes has a strong research background, having conducted significant work on improving blood stem cell engraftment after transplantation at Harvard and investigating genetic mutations in oral cancer at King's College London. He was also a Fulbright Scholar in 2012, which allowed him to further his studies in Switzerland.12 At Thuja, he focuses on addressing unmet medical needs and investing in diverse healthcare solutions, including therapies for infectious diseases and neurodegenerative conditions.1